Clinical Trial Update: A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects with HPV Positive HNSCC. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2a study evaluating BVAC-E6E7 in HPV-positive head and neck squamous cell carcinoma, with the trial currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hpv-associated Carcinoma
• Hpv-positive Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• BVAC-E6E7

Snippet

Sponsor: Cellid Co., Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC), HPV (human Papillomavirus)-Associated Carcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING